BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7356802)

  • 1. Bradykinin, plasma protein fraction, and hypotension.
    Ellison N; Behar M; MacVaugh H; Marshall BE
    Ann Thorac Surg; 1980 Jan; 29(1):15-9. PubMed ID: 7356802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin-mediated hypotension after infusion of plasma-protein fraction.
    Van Rosevelt RF; Bakker JC; Sinclair DM; Damen J; Van Mourik JA
    J Lab Clin Med; 1982 Aug; 100(2):288-95. PubMed ID: 6980251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator effects of the sodium acetate in pooled protein fraction.
    Olinger GN; Werner PH; Bonchek LI; Boerboom LE
    Ann Surg; 1979 Sep; 190(3):305-11. PubMed ID: 485604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive effects of plasma protein fraction. The relation between prekallikrein activator, bradykinin generation, and blood pressure in an animal model.
    Bleeker WK; Van Rosevelt RF; Ufkes JG; Loos JA; Van Mourik JA; Bakker JC
    J Lab Clin Med; 1982 Oct; 100(4):540-7. PubMed ID: 6981675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of autologous blood as part of the perfusate for cardiopulmonary bypass: a priming technique.
    Myers GJ; Legare JF; Sullivan JA; Leadon RB; Johnstone R; Swyer W; Squires C; Power C; Hirsch GM
    Perfusion; 2002 May; 17(3):211-6. PubMed ID: 12017390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The next generation of colloids: ready for "prime time"?
    Nussmeier NA; Searles BE
    Anesth Analg; 2009 Dec; 109(6):1715-7. PubMed ID: 19923493
    [No Abstract]   [Full Text] [Related]  

  • 7. The hypotensive effect of fresh lympholised plasma.
    Kaye SE
    Anaesth Intensive Care; 1976 Aug; 4(3):196-8. PubMed ID: 970603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction.
    Alving BM; Hojima Y; Pisano JJ; Mason BL; Buckingham RE; Mozen MM; Finlayson JS
    N Engl J Med; 1978 Jul; 299(2):66-70. PubMed ID: 661863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive effect of prekallikrein activator (PKA) in plasma protein fraction (PPF).
    Heinonen J; Peltola K; Himberg JJ; Suomela H
    Dev Biol Stand; 1980; 48():129-30. PubMed ID: 7024018
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypotension due to 5 per cent plasma protein fractions.
    Bland JH; Lavier MB; Lowenstein E
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006869
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic anaphylaxis secondary to the use of 5 per cent plasma protein fractions.
    McMillin RD; Hood TR; Griffen WO
    Am J Surg; 1978 May; 135(5):706-7. PubMed ID: 646044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactions to rapid infusion of stable plasma protein solution during large volume plasma exchange.
    Isbister JP; Biggs JC
    Anaesth Intensive Care; 1976 May; 4(2):105-7. PubMed ID: 937717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 esterase-inhibitor concentrate prevents hypotension from plasma-protein solutions.
    Van der Starre P; Sinclair D; Damen J; Brummelhuis H
    N Engl J Med; 1979 May; 300(22):1276. PubMed ID: 311888
    [No Abstract]   [Full Text] [Related]  

  • 14. SPPS and hypotension.
    Schiff P
    N Z Med J; 1992 May; 105(933):181. PubMed ID: 1589171
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitor from corn blocks the hypotensive action of plasma protein fraction and active Hageman factor.
    Marks E; Hojima Y; Frech ME; Keiser H; Pisano JJ
    Thromb Res; 1981 Jul 1-15; 23(1-2):97-102. PubMed ID: 6914060
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of the hypotensive effect of plasma protein solutions by C1 esterase inhibitor.
    van der Starre P; Sinclair D; Damen J; Brummelhuis H
    J Thorac Cardiovasc Surg; 1980 May; 79(5):738-40. PubMed ID: 7366239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of hypotensive effect of plasma protein fraction with prekallikrein activator activity: a clinical study in patients having open-heart surgery.
    Heinonen J; Peltola K; Himberg JJ; Suomela H
    Ann Thorac Surg; 1982 Mar; 33(3):244-9. PubMed ID: 6978689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hemodilution on hypotention during cardiopulmonary bypass.
    Gordon RJ; Ravin M; Daicoff GR; Rawitscher RE
    Anesth Analg; 1975; 54(4):482-8. PubMed ID: 1170785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting.
    Gallagher JD; Moore RA; Kerns D; Jose AB; Botros SB; Flicker S; Naidech H; Clark DL
    Anesth Analg; 1985 Aug; 64(8):753-8. PubMed ID: 2409845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.